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Background:  The Korean National Diabetes Program (KNDP) cohort study is performing an ongoing large-scale prospective 
multicenter investigation to discover the pathogenesis of type 2 diabetes in Korean patients. This study was performed to exam-
ine the prevalence of chronic complications in patients with type 2 diabetes among those registered in the KNDP cohort within 
the past 4 years.
Methods:  This study was performed between June 2006 and September 2009 at 13 university hospitals and included 4,265 KNDP 
cohort participants. Among the participants, the crude prevalence of microvascular and macrovascular diseases of those checked 
for diabetes-related complications was determined, and the adjusted standard prevalence and standardization of the general popu-
lation prevalence ratio (SPR) was estimated based on the 2005 Korean National Health and Nutrition Examination Survey 
(KNHANES) population demographics.
Results:  Among the KNDP registrants, 43.2% had hypertension, 34.8% had dyslipidemia, 10.8% had macrovascular disease, 
and 16.7% had microvascular disease. The SPR of the KNDP registrants was significantly higher than that of the KNHANES 
subjects after adjusting for demographics in the KNHANES 2005 population. However, with the exception of cardiovascular dis-
ease in females, the standardized prevalence for the most complicated items in the survey was significantly higher than that in 
the KNHANES subjects.
Conclusion:  The prevalence of macrovascular disease and peripheral vascular disease were significantly higher in Korean pa-
tients with type 2 diabetes than in the normal population. However, no significant difference was noted in the prevalence of car-
diovascular disease in females.
Keywords: Cerebrovascular disorders; Coronary disease; Diabetes mellitus, type 2; Diabetic retinopathy; Korea
Corresponding author:  Young Seol Kim 
Department of Endocrinology and Metabolism, Kyung Hee University 
School of Medicine, 1 Hoegi-dong, Dongdaemoon-gu, Seoul 130-702, Korea
Tel: +82-2-958-8200, Fax: +82-2-968-1848, E-mail: kimys@khmc.or.kr
Received: Aug. 6, 2010; Accepted: Mar. 30, 2011
*		 Sang Youl Rhee and Suk Chon contributed equally to this study as first 
authors.
Original Article
http://dx.doi.org/10.4093/dmj.2011.35.5.504
pISSN 2233-6079 · eISSN 2233-6087505
Prevalence of complications in Korean type 2 DM patients
Diabetes Metab J 2011;35:504-512 http://e-dmj.org
INTRODUCTION
Diabetes is associated with chronic diseases such as hyperten-
sion, dyslipidemia, and various other chronic complications 
including large artery diseases such as coronary artery disease, 
cerebrovascular disease, and peripheral vascular disease, as 
well as retinopathy, nephropathy, neuropathy, microvascular 
disease, autonomic nervous system diseases, skin diseases, and 
infectious diseases. These diseases are often the direct causes 
of death in patients with diabetes [1,2].
  The prevalence of chronic complications from diabetes is 
generally thought to be dependent on the duration of diabetes, 
and the extent and occurrence of chronic complications are 
strongly associated with the degree of glycemic control. This 
explains the necessity for intensive glycemic control in patients 
with diabetes [3-6]. The prevalence of chronic complications 
from diabetes is increasing, and the mortality rate is also ex-
pected to increase significantly [7-9]. However, few systematic 
studies on chronic complications are available in Korean pa-
tients with type 2 diabetes.
  A national-scale research project was implemented in May 
2005 by the Korean National Diabetes Program (KNDP) to 
study prevention, treatment, and management of type 2 diabe-
tes in Korean patients. Through the KNDP, researchers are go-
ing to establish suitable prevention, diagnostic, and treatment 
guidelines by studying the characteristics of Korean patients 
with type 2 diabetes. Clinical epidemiological research, clini-
cal trials led by researchers, and clinical practice guidelines for 
standards of diabetes are being performed and developed 
through a specific KNDP project, and a cohort study is cur-
rently being conducted in patients with type 2 diabetes and in 
patients at high risk for developing diabetes. This study was 
expected to identify the pathophysiology and clinical charac-
teristics of Korean patients at high risk for developing diabetes 
and those with type 2 diabetes.
  This study was conducted between 2005 and 2009 on pa-
tients who were registered for the KNDP cohort study based 
on their baseline clinical data, to confirm the prevalence of 
chronic complications in Korean patients with type 2 diabetes. 
In addition, data were compared to the examined prevalence 
of chronic diseases through the Korean National Health and 
Nutritional Examination Survey (KNHANES) 2005 to confirm 
relative risk to the general population.
METHODS
KNDP cohort study
KNDP cohort studies are prospective, multicenter, and obser-
vational studies performed on Korean patients with type 2 dia-
betes and patients at high risk for diabetes. The first patients 
were enrolled in May 2006, and we are expecting to make pri-
mary observations on registered participants until March 2014.
  The KNDP cohort was composed of 2 groups, patients with 
type 2 diabetes and patients at high risk for diabetes. The type 
2 diabetes cohort was composed of patients who had satisfied 
the diagnostic criteria set by the American Diabetes Associa-
tion in 2004 and who were at least 20 years old [10]. Subjects 
with impaired fasting glucose or impaired glucose tolerance, 
as well as subjects who had met the diagnostic criteria for ges-
tational diabetes, were identified as high risk subgroup for dia-
betes [10].
  The KNDP cohort study was performed at the following 13 
research hospitals: Kyung Hee University Hospital, Kyung Hee 
University Hospital at Gangdong, Korea University Guro Hos-
pital, Ajou University Hospital, Inha University Hospital, Han-
yang University Guri Hospital, Gachon Medical School Gil 
Hospital, Pusan National University Hospital, Kwandong Uni-
versity Cheil General Hospital and Women’s Healthcare Cen-
ter, Yeungnam University Medical Center, Inje University 
Sanggye Baik Hospital, Hallym University Gangdong Sacred 
Heart Hospital, and the Catholic University of Korea Uijeong-
bu St. Mary’s Hospital. Among these, the Catholic University 
of Korea Uijeongbu St. Mary’s Hospital only worked with the 
high-risk diabetes cohort, whereas the other 12 hospitals 
worked with both the diabetes cohort and the high-risk diabe-
tes cohort. Prior to performing the KNDP cohort study, each 
hospital received approval from the Institutional Review Board, 
and all participants gave their written consent after receiving a 
full study summary.
  The KNDP cohort clinical data consisted of medical histo-
ries, physical examinations, laboratory tests, and surveys. Each 
survey item was provided as it appeared in the KNDP research-
er manual, and surveys were conducted at 6 months, 1 year, 
and 3 years. The primary outcomes of the KNDP cohort were 
mortality, diabetes-related microvascular complications, and 
macrovascular complications. The secondary outcomes were 
the factors causing diabetes related mortality and complica-
tions. The tertiary outcomes were made separately based on 
the detailed research projects of each hospital that participated 506
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in the KNDP cohort study. The final decisions regarding the 
complications of study participants were made by the KNDP 
complications decision committee, which consisted of experts 
in each field, to ensure objectivity of the diagnoses.
  The number of participants in the KNDP diabetes cohort 
was estimated by means of an exposure factors that affected 
the primary outcomes of the participants. The rate of occur-
rence of complications was 5%, relative risk was 1.5%, α was 
90%, and power (1-β) was 80% for the expression factor-ex-
posed group and for the sample size of the non-expression 
group. The sample size of the expression group was assumed 
to be 0.5, and that at the end of the observations was estimated 
to be 940 for the expression group (exposed) and 1,880 in the 
non-expression group, which required approximately 2,820 
samples. Assuming that the annual dropout rate was 5%, the 
estimated number of KNDP cohort subjects was 4,250.
  All of the data associated with the KNDP cohort were re-
corded in the KNDP written case records, and all data were 
entered, maintained, and managed with active internet-based 
electronic case report forms (eCRF, http://www.kndp.or.kr) at 
each of the organized research institutions.
Subjects
Until September 2009, total 4,265 subjects were enrolled in the 
KNDP diabetes cohort. Among the 4,265 registered KNDP 
patients that were in the type 2 diabetes cohort, 3,795 had sub-
mitted surveys regarding their diabetes-related chronic com-
plications by September 2009. Patients were excluded if they 
had not completed their medical history survey by September 
2009 or if their clinical information had not been registered 
with the KNDP eCRF.
Methods
During registration of the KNDP diabetes cohort, age, gender, 
diabetes duration, height, weight, waist circumference, resting 
blood pressure, and other baseline clinical characteristics were 
surveyed for all of the subjects, and blood samples were col-
lected to test for fasting plasma glucose, glycated hemoglobin, 
and serum lipid profiles, as well as other biochemical tests. In 
addition, hypertension, dyslipidemia and associated diseases, 
various macrovascular diseases associated with diabetes, and a 
history of complications from vascular disease were verified 
through surveys. The investigated macrovascular disease com-
plications were cardiovascular diseases such as myocardial in-
farction, angina, congestive heart failure, atrial fibrillation, ce-
rebral infarction, transient cerebral ischemia, peripheral arte-
rial disease, amputation, and foot ulcers, as well as a history of 
percutaneous transluminal coronary angioplasty, a coronary 
artery bypass graft, or a stent implantation from a cerebrovas-
cular hemorrhage. When the study subjects were unable to 
identify their cerebrovascular disease, they were classified as 
“unspecified stroke.” In addition, vascular diseases related to 
major complications of the eyes such as retinopathy, cataracts, 
glaucoma, history of photocoagulation, retinal surgery, and 
cataract surgery were evaluated. However, because of the on-
going prospective nature of the study, the KNDP cohort used 
in this study relied on baseline data and not on recently ob-
served data or new clinical outcomes.
  The crude prevalence of diabetes-related complications for 
macrovascular and microvascular diseases of the participants 
was calculated based on the baseline medical history of the 
surveyed participants. However, the survey data from the larg-
est national health survey in Korea, the KNHANES 2005, were 
used to standardize incidence to directly compare the calcu-
lated classification of the organization of the gender and age of 
subjects registered to the KNDP cohort of the general popula-
tion to that of the population that participated in this study. In 
total, 25,215 males and females >15 years old were surveyed 
in the third phase of the KNHANES 2005, and their chronic 
disease histories were collected, including hypertension, dys-
lipidemia, cerebrovascular disease, myocardial infarction, an-
gina, cataracts, or glaucoma. This confirmed the prevalence of 
diabetes-related chronic diseases based on the findings of the 
KNDP survey. The adjusted standard prevalence of chronic 
complications in the KNDP cohort registrants was estimated 
based on age and gender demographics using the direct stan-
dardization method. An indirect standardization method, 
which is based on the demographics of the Korean population 
in 2005, was used to estimate the standardized prevalence ra-
tio (SPR) to confirm the comparative risk of complications in 
the KNDP cohort registrants to that of the general population 
[11,12].
Analysis
SPSS version 13.0 (SPSS Inc., Chicago, IL, USA) was used to 
perform the statistical analysis and data management. The de-
scriptive statistics of the clinical variables are expressed as 
means and standard deviations, and the Student’s t and chi-
square tests were used to confirm statistical significance be-
tween males and females. P values of less than 0.05 were con-507
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sidered significant.
RESULTS
Participant clinical characteristics 
Among the 3,795 participants who were included in the analy-
sis, 2,142 were male and 1,653 were female. The mean age of 
these individuals was 54.0 years, and the mean diabetes dura-
tion was 6.0 years (Table 1). The mean body mass index (BMI) 
of the participants was 25.1 kg/m
2, mean waist circumference 
was 87.9 cm, mean fasting plasma glucose was 147.5 mg/dL, 
and mean glycated hemoglobin was 7.8%.
  Significant gender-based differences were observed in 
many of the surveyed clinical variables (Table 1). Diastolic 
blood pressure, fasting glucose, glycated hemoglobin, triglyc-
erides, aspartate transaminase, alanine transaminase, and 
γ-glutamyltransferase were significantly higher in males than 
in females, and mean age, diabetes duration, BMI, and total 
cholesterol were relatively higher in females than in males. 
Significant differences in systolic blood pressure and high sen-
sitivity C-reactive protein concentrations between genders 
were not observed. 
  There were significantly more male current smokers, ex-
smokers, ex-drinkers, and current drinkers than female ones 
(Table 1).
Table 1. Baseline characteristics of the study subjects
Characteristic Male (n=2,142) Female (n=1,653) P value Total (n=3,795)
Age, yr 52.3±10.3 56.3±10.2 <0.001 54.0±10.4
DM duration, yr 5.7±6.2 6.4±6.8 <0.003 6.0±6.5
BMI, kg/m
2 25.0±3.0 25.3±3.5 0.019 25.1±3.2
AC, cm 89.1±7.7 86.3±8.5 <0.001 87.9±8.2
SBP, mm Hg 125.7±14.7 125.5±15.4 0.792 125.6±15.0
DBP, mm Hg 79.0±9.9 77.3±9.7 <0.001  78.3±9.8
FPG, mg/dL 150.5±53.8 143.7±53.9 <0.001 147.5±53.9
HbA1c, % 7.8±2.0 7.7±1.7 0.009 7.8±1.9
TC, mg/dL 178.9±40.6 186.9±41.8 <0.001 182.4±41.3
TG, mg/dL 172.5±139.6 149.6±95.9 <0.001 162.5±123.1
BUN, mg/dL 15.0±4.6 14.4±5.2 <0.001 14.7±4.9
Creatinine, mg/dL 0.9±0.2 0.7±0.3 <0.001 0.84±0.30
AST, IU/L 27.1±21.3 24.6±13.9 <0.001 26.0±18.5
ALT, IU/L 32.8±29.5 25.9±17.6 <0.001 29.7±25.2
γGT, mg/dL 61.2±101.1 30.5±34.9 <0.001 47.7±80.7
hsCRP, mg/dL 1.92±11.81 2.43±16.85 0.446 2.2±14.3
Smoking status (n=3,717)
Never, n (%) 443 (21.1) 1,514 (93.5) <0.001 1,957 (52.6)
Ex-smoker, n (%) 899 (42.9) 45 (2.8) 944 (25.4)
Current, n (%) 755 (36.0) 61 (3.7) 816 (22.0)
Alcohol status (n=3,711)
Never, n (%) 361 (17.2) 1,158 (71.7) <0.001 1,519 (40.9)
Previous drinker, n (%) 322 (15.4) 105 (6.5) 427 (11.5)
Current drinker, n (%) 1,412 (67.4) 353 (21.8) 1,765 (47.6)
Mean±standard deviation by independent sample t-test and chi-square test.
BMI, body mass index; AC, abdominal circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; 
TC, total cholesterol; TG, triglyceride; BUN, blood urea nitrogen; AST, aspartate aminotransferas; ALT, alanine aminotransferase; hsCRP, high 
sensitivity C-reactive protein.508
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Crude prevalence of chronic complications 
The crude prevalence of hypertension in all KNDP diabetes 
cohort subjects was 43.2%, and the crude prevalence of dyslip-
idemia was 34.8% (Table 2). Some gender-related differences 
were noted; for example, hypertension and dyslipidemia were 
significantly more prevalent in females.
  The prevalence of macrovascular disease in the KNDP reg-
istrants was 10.8% (Table 2). The prevalence of cardiovascular 
disease, cerebrovascular disease, and peripheral vascular dis-
ease in the study subjects was 5.5%, 5.0%, and 1.1%, respec-
tively. The prevalence of a history of myocardial infarction and 
stent implantation was significantly higher in male than in fe-
male patients, although no significant gender-based differenc-
es were observed for any other items. The crude prevalence of 
microvascular disease was 16.7%, and a significant difference 
was observed between the genders (13.1% in men vs. 21.3% 
women; Table 2). When each item was examined, the incidenc-
es of retinopathy, cataracts, and related surgery history were 
significantly higher in females than in males, but no signifi-
cant gender-based differences were observed regarding history 
of glaucoma or photocoagulation.
Standardized prevalence of chronic complications in the 
National Health and Nutrition Examination Survey
Among the KNHANES 2005 subjects, the rates of diabetes-re-
lated chronic complications in the 25,215 patients that were at 
least 15 years old were 14.9%, 3.2%, 1.9%, 0.6%, 1.4%, 5.5%, 
and 0.7% for the presence of a chronic history of hypertension, 
dyslipidemia, cerebrovascular disease, myocardial infarction, 
angina, cataracts, and glaucoma, respectively (Table 3). A sig-
nificant difference was observed between genders in the prev-
alence of hypertension, angina, cataracts, and glaucoma, which 
were significantly higher in females.
  The adjusted standardized overall prevalence of the KNDP 
registrants had a tendency to decrease compared to the crude 
prevalence. The adjusted standardized values for hypertension, 
dyslipidemia, cerebrovascular disease, myocardial infarction, 
angina, cataracts, and glaucoma were 27.9%, 22.6%, 3.2%, 1.1%, 
1.8%, 7.8%, and 1.3%, respectively (Table 4). However, using 
an indirect standardized method, the comparative results 
showed that most of the items that were examined in the KNDP 
registrants were significantly higher compared to those of the 
KNHANES subjects, such that prevalence increased by 1.87-
fold for hypertension, 1.72-fold for cerebrovascular disease, 
1.79-fold for myocardial infarction, 1.42-fold for cataracts, 
Table 2. Crude prevalence of type 2 diabetes-related chronic 
complications in the study subjects
Variable Male 
(n=2,142)
Female 
(n=1,653)
Total 
(n=3,795)
Comorbidity
Hypertension
a 857 (40.0) 782 (47.3)  1,639 (43.2) 
Dyslipidemia
a 699 (32.6) 622 (37.6)  1,321 (34.8) 
Macrovascular complication
Cardiovascular disease
MI
a 51 (2.4)  19 (1.1)  70 (1.8) 
Angina 58 (2.7)  47 (2.8)  105 (2.8) 
HF 9 (0.4)  4 (0.2)  13 (0.3) 
Af 4 (0.2)  7 (0.4)  11 (0.3) 
PTCA 22 (1.0)  10 (0.6)  32 (0.8) 
CABG 5 (0.2)  3 (0.2)  8 (0.2) 
Stent
a 38 (1.8)  10 (0.6)  48 (1.3) 
Total 129 (6.0)  79 (4.8)  208 (5.5) 
Cerebrovascular disease
Cb hemorrhage 18 (0.8)  19 (1.1)  37 (1.0) 
Cb infarction 66 (3.1)  50 (3.0)  116 (3.1) 
TIA 2 (0.1)  6 (0.4)  8 (0.2) 
Unspecified stroke 14 (0.7)  18 (1.1)  32 (0.8) 
Total 100 (4.7)  90 (5.4)  190 (5.0) 
Peripheral 
PAD 16 (0.7)  12 (0.7)  28 (0.7) 
Amputation 3 (0.1)  0 (0.0)  3 (0.1) 
Foot ulcer 5 (0.2)  6 (0.4)  11 (0.3) 
Total 24 (1.1)  18 (1.1)  42 (1.1) 
Total macrovascular issues 236 (11.0)  175 (10.6)  411 (10.8) 
Microvascular disease
Retinopathy
a 124 (5.8)  142 (8.6)  266 (7.0) 
Cataract
a 147 (6.9)  239 (14.5)  386 (10.2) 
Glaucoma 30 (1.4)  34 (2.1)  64 (1.7) 
Photocoagulation 28 (1.3)  33 (2.0)  61 (1.6) 
Retina Op
a 20 (0.9)  34 (2.1)  54 (1.4) 
Cataract Op
a 73 (3.4)  105 (6.4)  178 (4.7) 
Total
a 280 (13.1)  352 (21.3)  632 (16.7) 
Values are presented as number (%).
aStatistically significant between males and females by chi-square test 
(P<0.05).
MI, myocardial infarction; HF, heart failure; Af, atrial fibrillation; 
PTCA, percutaneous transluminal coronary angioplasty; CABG, 
coronary artery bypass graft; Cb, cerebral; TIA, transient ischemic at-
tack; PAD, peripheral arterial disease; Op, operation.509
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and 1.94-fold for glaucoma. Dyslipidemia was particularly 
high, with a 7.10-fold increased prevalence in the KNDP reg-
istrants. However, angina in the KNDP registrants was 1.24 
times higher than that in the KNHANES participants, although 
this difference was not statistically significant. When this re-
sult was analyzed by gender, the prevalence of all surveyed 
complications in males was significantly higher in the KNDP 
cohort registrants than that in the KNHANES subjects. How-
ever, no significant differences were observed for cardiovascu-
lar complications such as myocardial infarction or angina in 
females (Table 4).
DISCUSSION
The prevalence of chronic complications due to type 2 diabe-
Table 3. Prevalence of type 2 diabetes-related complications in 
the KNHANES 2005 population
Variable Male 
(n=11,726)
Female 
(n=13,489)
Total 
(n=25,215)
Hypertension
a 1,666 (14.2) 2,100 (15.6) 3,766 (14.9)
Dyslipidemia 396 (3.4) 405 (3.0) 801 (3.2)
Cerebrovascular disease 238 (2.0) 236 (1.8) 474 (1.9)
MI 84 (0.7) 75 (0.6) 159 (0.6)
Angina
a 133 (1.1) 230 (1.8) 363 (1.4)
Cataract
a 469 (4.0) 915 (6.8) 1,384 (5.5)
Glaucoma
a 64 (0.5) 107 (0.8) 171 (0.7)
Values are presented as number (%).
KNHANES, Korea National Health and Nutrition Examination Sur-
vey; MI, myocardial infarction
aStatistically significant between males and females by the chi-square 
test (P<0.05).
Table 4. Standardized prevalence of type 2 diabetes-related chronic complications in the study subjects
Disease entity KNDP cases, No. Crude prevalence, % Standardized prevalence, % SPR
a 95% CI
Total
Hypertension 1,639 43.2 27.9 1.87 1.78-1.96
Dyslipidemia 1,321 34.8 22.6 7.10 6.71-7.49
Cerebrovascular disease 190 5.0 3.2 1.72 1.47-1.97
MI 70 1.8 1.1 1.79 1.36-2.22
Angina
b 105 2.8 1.8 1.24 1.00-1.48
Cataract 386 10.2 7.8 1.42 1.28-1.57
Glaucoma 64 1.7 1.3 1.94 1.46-2.43
Males
Hypertension 857 40.0 28.0 1.97 1.84-2.11
Dyslipidemia 699 32.6 24.1 7.13 6.59-7.67
Cerebrovascular disease 100 4.7 3.4 1.66 1.33-1.99
MI 51 2.4 1.7 2.36 1.70-3.03
Angina 58 2.7 2.0 1.77 1.31-2.24
Cataract 147 6.9 5.5 1.37 1.15-1.60
Glaucoma 30 1.4 1.2 2.18 1.38-2.97
Females
Hypertension 782 47.3 27.1 1.74 1.62-1.87
Dyslipidemia 622 37.6 20.1 6.68 6.14-7.21
Cerebrovascular disease 90 5.4 3.0 1.73 1.37-2.10
MI
b 19 1.2 0.6 1.08 0.58-1.57
Angina
b 47 2.8 1.6 0.93 0.66-1.20
Cataract 239 14.5 9.8 1.44 1.25-1.63
Glaucoma 34 2.1 1.4 1.77 1.17-2.38
KNDP, Korea National Diabetes Program; SPR, standardized prevalence ratio; CI, confidence interval; MI, myocardial infarction.
aStatistically not significant.510
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tes is affected by the study population, patient characteristics 
such as age, diabetes duration, and the diagnostic methods 
used to identify the complication. However, the prevalence of 
cardiovascular disease, stroke, and retinopathy in Europe and 
North America range between 10.5% to 30.8%, 4.1% to 12.3%, 
and approximately 10.6% to 36%, respectively, whereas those 
in the Asia-Pacific region range from 10.5% to 18.1%, 3.7% to 
7.5%, and 32.1% to 35.9%, respectively [13-22]. Although some 
cross-sectional studies are available on patients who have been 
admitted to Korean hospitals, the prevalence of cardiovascular 
disease, stroke, and retinopathy in this study was 7.8%, 8.4%, 
and 35.2%, respectively [23]. When using the initial KNDP 
cohort registration data, the results showed that the prevalence 
of hypertension and dyslipidemia in patients with type 2 dia-
betes was 43.2% and 34.8%, respectively, whereas those of 
macrovascular disease and microvascular disease due to com-
plications of the eye were 10.8% and 16.7%, respectively. In 
addition, in almost all of the chronic complication items, the 
SPR of the KNDP registrants and the prevalence of chronic 
complications were both significantly higher in patients with 
type 2 diabetes than in the general population. The exact sta-
tistics for Korean patients with type 2 diabetes regarding the 
prevalence of chronic complications do not exist, whereas the 
results from this study accurately reflect the current status of 
the disease and serve as an objective basis.
  In this study, the observation of significant gender-based 
differences among Korean patients with type 2 diabetes is worth 
mentioning. First, males had significantly higher fasting plas-
ma glucose, glycated hemoglobin, triglycerides, and other 
items at baseline, whereas mean age, diabetes duration, and 
total cholesterol were significantly higher in females than in 
males. Second, the prevalence of a history of acute myocardial 
infarction, stent implantation, and other items related to mac 
rovascular complications was significantly higher in males 
than in females. However, significantly more hypertension, 
dyslipidemia, chronic diseases, retinopathy, cataracts, and mi-
crovascular complications were observed in females than in 
males. Third, of all items surveyed in the KNDP registrants, 
the SPR was significantly higher in males than in the general 
population. Females showed no significant differences in car-
diovascular diseases such as angina or myocardial infarction 
compared to the general population. 
  These gender-based differences in the baseline clinical char-
acteristics of the KNDP registrants may be the cause of the 
differences based on diabetes duration and the degree of dia-
betes management. In other words, these gender-based differ-
ences may be due to a simple bias. However, it is necessary to 
review the high mortality rate of middle-aged men and the 
possibility of reflecting the actual survival of Korean females. 
The reason that females who were registered with the KNDP 
were not significantly different from the general population 
regarding cardiovascular disease SPR was that mean age, dia-
betes duration of the recruited patients, and the prevalence of 
chronic complications were lower than those in registered pa-
tients. This was due to the fact that there were many pre-meno-
pausal females that had a relatively low risk of cardiovascular 
disease. Whether or not current KNDP registrants were meno-
pausal was not examined in detail. However, information re-
lated to the occurrence of important risk factors associated 
with macrovascular complications should be further studied 
in the future.
  There are several limitations to this study. First, although 
this study was based on data from a prospective cohort study, 
only the initial registered data were used for the analysis. It 
was also a cross-sectional study, although additional informa-
tion other than relative risk on prevalence and the general 
population was obtained. Second, as this study is part of an 
ongoing larger study, data were missing due to clinical data 
that were not collected; thus, a census for the KNDP cohort 
registrants could not be achieved. Third, because the compli-
cation prevalence of patients was determined through medical 
interviews and not by examination, the results are based on 
statements made by the registrants, which introduces the pos-
sibility of error. Fourth, the results can be interpreted slightly 
differently, due to the differences in the surveying method or 
the survey items between the KNDP cohort and KNHANES. 
In particular, the KNHANES randomly selected participants 
from the general population, whereas the KNDP cohort study 
was performed on patients who had been admitted to univer-
sity hospitals. This may have resulted in excluding patients 
from the cohort who already had a history of clinically severe 
cardiovascular disease. Finally, the main medical institutions 
where the KNDP cohort study was conducted are located in 
Seoul and the Seoul metropolitan area, and the university hos-
pitals are located around Yeungnam and other locations 
throughout Korea. These location differences limit how accu-
rately primary and secondary medical institutions reflect the 
conditions of the admitted patients with diabetes. However, 
the majority of these limitations can be resolved through ob-
servation and by continuously tracking the clinical results of 511
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future KNDP registrants. In the future, trends in the change in 
prevalence of chronic complications can be confirmed in Ko-
rean patients with type 2 diabetes based on the progress of this 
cohort study, and new incidences of complications can also be 
estimated. The differences in the occurrence of complications 
based on treatment method can be verified; thus, it is possible 
to verify whether the identified gender-related differences are 
meaningful. 
  The number of patients with type 2 diabetes is increasing 
sharply throughout the world and is becoming an increasingly 
important global health issue [24]. However, not all symptoms 
associated with diabetes are common in all regions of the world. 
Many researchers believe that race, genetics, social class, life-
style, and other factors have complex effects on the patho-
physiology of diabetes, resulting in worldwide diversity [25]. 
In this respect, it is necessary to perform a systematic study to 
better understand prevention and treatment methods specifi-
cally for Korean patients with diabetes. Among all of the dia-
betes cohort studies that are currently underway in Korea, the 
most extensive is the KNDP cohort study, which is expected to 
continuously confirm important clinical characteristics of pa-
tients with type 2 diabetes.
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